<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consortium PSYCHIATRICUM</journal-id><journal-title-group><journal-title xml:lang="en">Consortium PSYCHIATRICUM</journal-title><trans-title-group xml:lang="ru"><trans-title>Consortium PSYCHIATRICUM</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2712-7672</issn><issn publication-format="electronic">2713-2919</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">15803</article-id><article-id pub-id-type="doi">10.17816/CP15803</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEW</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОР</subject></subj-group><subj-group subj-group-type="article-type"><subject>Unknown</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Small Extracellular Vesicles in Alcohol Use Disorders: A Scoping Review</article-title><trans-title-group xml:lang="ru"><trans-title>Малые внеклеточные везикулы при расстройствах, вызванных употреблением алкоголя: обзор предметного поля</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8712-3561</contrib-id><contrib-id contrib-id-type="spin">5969-2020</contrib-id><name-alternatives><name xml:lang="en"><surname>Severtsev</surname><given-names>Vsevolod V.</given-names></name><name xml:lang="ru"><surname>Северцев</surname><given-names>Всеволод Владиславович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci (Med.), Assistant professor at the Department of Psychiatry and Addiction Medicine, N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>Кандидат медицинских наук, ассистент кафедры психиатрии и наркологии Института клинической медицины им. Н.В. Склифосовского</p></bio><email>severtsevmed@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-5217-8874</contrib-id><name-alternatives><name xml:lang="en"><surname>Kamalieva</surname><given-names>Emilia Ramilevna</given-names></name><name xml:lang="ru"><surname>Камалиева</surname><given-names>Эмилия Рамилевна</given-names></name></name-alternatives><bio xml:lang="en"><p>6th-year student at the N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>студентка 6-го курса Института клинической медицины им. Н.В. Склифосовского</p></bio><email>severtsevmed@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3247-9015</contrib-id><name-alternatives><name xml:lang="en"><surname>Sklyar</surname><given-names>Elena  Yuryevna</given-names></name><name xml:lang="ru"><surname>Скляр</surname><given-names>Елена Юрьевна</given-names></name></name-alternatives><bio xml:lang="en"><p>6th-year student at the N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>Студентка 6-го курса Института клинической медицины им. Н.В. Склифосовского</p></bio><email>severtsevmed@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-7590-7840</contrib-id><contrib-id contrib-id-type="spin">6111-3980</contrib-id><name-alternatives><name xml:lang="en"><surname>Pevunova</surname><given-names>Anastasia  Romanovna</given-names></name><name xml:lang="ru"><surname>Певунова</surname><given-names>Анастасия  Романовна</given-names></name></name-alternatives><bio xml:lang="en"><p>Resident physician</p></bio><bio xml:lang="ru"><p>Ординатор </p></bio><email>severtsevmed@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-8869-2254</contrib-id><name-alternatives><name xml:lang="en"><surname>Finko</surname><given-names>Elizaveta  Vasilievna</given-names></name><name xml:lang="ru"><surname>Финько</surname><given-names>Елизавета  Васильевна</given-names></name></name-alternatives><bio xml:lang="en"><p>6th-year student at the N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>Студентка 6-го курса Института клинической медицины им. Н.В. Склифосовского</p></bio><email>severtsevmed@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-8202-7642</contrib-id><name-alternatives><name xml:lang="en"><surname>Galeeva</surname><given-names>Milyausha  Shamilevna</given-names></name><name xml:lang="ru"><surname>Галеева</surname><given-names>Миляуша  Шамилевна</given-names></name></name-alternatives><bio xml:lang="en"><p>Resident physician, the Department of Psychiatry and Addiction Medicine, N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>Ординатор кафедры психиатрии и наркологии Института клинической медицины им. Н.В. Склифосовского </p></bio><email>severtsevmed@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0013-5031</contrib-id><contrib-id contrib-id-type="researcherid">N-3993-2014</contrib-id><contrib-id contrib-id-type="spin">3038-0090</contrib-id><name-alternatives><name xml:lang="en"><surname>Ivanets</surname><given-names>Nikolay  Nikolaevich</given-names></name><name xml:lang="ru"><surname>Иванец</surname><given-names>Николай  Николаевич</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, Dr. Sci (Med.), Professor, Corresponding Member of the Russian Academy of Sciences, Head of the Department of Psychiatry and Narcology, N.V. Sklifosovsky Institute of Clinical Medicine </p></bio><bio xml:lang="ru"><p>Доктор медицинских наук, профессор, член-корреспондент РАН, заведующий кафедрой психиатрии и наркологии Института клинической медицины им. Н.В. Склифосовского </p></bio><email>severtsevmed@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Сеченовский Университет)</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Scientific and Practical Center for Mental Health of Children and Adolescents named after G.E. Sukhareva</institution></aff><aff><institution xml:lang="ru">ГБУЗ «Научно-практический центр психического здоровья детей и подростков им. Г.Е. Сухаревой ДЗМ г. Москвы»</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2026-05-15" publication-format="electronic"><day>15</day><month>05</month><year>2026</year></pub-date><volume>7</volume><issue>2</issue><issue-title xml:lang="ru"/><history><date date-type="received" iso-8601-date="2025-12-08"><day>08</day><month>12</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2026-05-15"><day>15</day><month>05</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; , Severtsev V.V., Kamalieva E.R., Sklyar E. ., Pevunova A.R., Finko E.V., Galeeva M. ., Ivanets N.N.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; , Северцев В.В., Камалиева Э.Р., Скляр Е.Ю., Певунова А.Р., Финько Е.В., Галеева М.Ш., Иванец Н.Н.</copyright-statement><copyright-holder xml:lang="en">Severtsev V.V., Kamalieva E.R., Sklyar E. ., Pevunova A.R., Finko E.V., Galeeva M. ., Ivanets N.N.</copyright-holder><copyright-holder xml:lang="ru">Северцев В.В., Камалиева Э.Р., Скляр Е.Ю., Певунова А.Р., Финько Е.В., Галеева М.Ш., Иванец Н.Н.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consortium-psy.com/jour/article/view/15803">https://consortium-psy.com/jour/article/view/15803</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND: </bold>Alcohol consumption is one of the most significant global public health challenges. The pathophysiology of alcohol use disorder remains only partially elucidated, and direct biomarkers for this disorder have yet to be identified. Some studies have investigated the profiles of small extracellular vesicles (sEVs) in different bodily fluids. However, the findings across these studies are heterogeneous, and the methodological quality of these studies has not been systematically assessed.<bold>AIM:</bold> To summarize the results of studies examining the sEVs profiles in alcohol use disorders.<bold>METHODS: </bold>The review included original research articles that explored the sEVs profiles in alcohol use disorders. The PubMed (for studies published up to November 2025) and Scopus (for studies published up to January 10, 2026) databases were searched. The analysis of the included studies was conducted using a descriptive evidence synthesis approach based on the categories of lipid profile, protein profile, and signaling molecules. The methodological quality of the studies was assessed using the Newcastle–Ottawa Scale (NOS) adapted for extracellular vesicle research. <bold>RESULTS:</bold> Ten studies were included. All studies employed a cross-sectional design, were conducted in small cohorts, and included patients with acute and chronic alcohol intoxication, as well as those with alcohol use disorders. Significant differences in the sEVs profiles were identified in individuals with alcohol use disorders compared to healthy controls. These differences encompassed modifications in lipid and protein profiles, decreased expression of hsa-miR-144-5p, hsa-miR-182-5p, hsa-miR- 142-5p, hsa-miR-7-5p, hsa-miR-15b-5p, and hsa-circ-0004771, an increased expression of miR30a-5p and miR-194-5p, as well as alterations in inflammatory response parameters. The majority of these differences were related to the regulation of inflammation. <bold>CONCLUSION: </bold>In alcohol use disorders, sEVs differ in lipid and protein profiles as well as in microRNA expression. New studies are needed to investigate the impact of sEVs on the regulation of systemic inflammation in alcohol use disorders using a prospective design with repeated measurements of specific sEV characteristics. </p></abstract><trans-abstract xml:lang="ru"><p><bold>ВВЕДЕНИЕ: </bold>Употребление алкоголя — одна из наиболее значимых глобальных проблем здравоохранения. Патофизиология синдрома зависимости от алкоголя изучена лишь частично, прямые биомаркеры данного расстройства не определены. В ряде исследований применительно к синдрому зависимости от алкоголя изучался состав малых внеклеточных везикул (мВВ) в различных биологических средах. Однако результаты этих исследований неоднородны, а методологическое качество работ систематически не оценивалось.<bold>ЦЕЛЬ: </bold>Обобщить результаты исследований состава мВВ при расстройствах, вызванных употреблением алкоголя.<bold>МЕТОДЫ: </bold>В обзор включали оригинальные исследования, в которых изучался состав мВВ при расстройствах, связанных с употреблением алкоголя. Поиск осуществлялся в базах данных PubMed (работы, опубликованные до ноября 2025 г.) и Scopus (работы, опубликованные до 10 января 2026 г.). Анализ вошедших в обзор работ выполнен с использованием метода описательного синтеза по категориям «липидный состав», «белковый состав» и «сигнальные молекулы» мВВ. Методологическое качество исследований оценивали с применением «Шкалыоценки качества Ньюкасл–Оттава» (NOS), модифицированной для исследований внеклеточных везикул.<bold>РЕЗУЛЬТАТЫ:</bold> В обзор включено 10 исследований. Все исследования имели поперечный дизайн, были проведенына небольших выборках и включали пациентов с острой и хронической интоксикацией, а также с синдромомзависимости. Выявлены значимые отличия состава мВВ при расстройствах, вызванных употреблением алкоголя,по сравнению со здоровыми добровольцами: модификации липидного и белкового состава, более низкая экспрессия hsa-miR-144-5p, hsa-miR-182-5p, hsa-miR-142-5p, hsa-miR-7-5p, hsa-miR-15b-5p и hsa-circ-0004771, более высокая экспрессия miR-30a-5p и miR-194-5p, а также отличия параметров воспалительного ответа. Большинство обнаруженных отличий ассоциированы с регуляцией воспаления.<bold>ЗАКЛЮЧЕНИЕ:</bold> При расстройствах, связанных с употреблением алкоголя, мВВ отличаются по составу липидов, белков и экспрессии микроРНК. Необходимы новые исследования влияния мВВ на регуляцию системного воспаления при синдроме зависимости от алкоголя с проспективным дизайном и повторными измерениями специфичных характеристик мВВ.</p></trans-abstract><kwd-group xml:lang="en"><kwd>alcohol dependence syndrome</kwd><kwd>small extracellular vesicles</kwd><kwd>exosomes</kwd><kwd>microRNA</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>расстройства, вызванные употреблением алкоголя</kwd><kwd>малые внеклеточные везикулы</kwd><kwd>экзосомы</kwd><kwd>микроРНК</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="en">RSF</institution></institution-wrap><institution-wrap><institution xml:lang="ru">РНФ</institution></institution-wrap></funding-source><award-id>№ 25-75-00120</award-id></award-group><funding-statement xml:lang="en">The study was supported by the Russian Science Foundation, grant No. 25-75-00120 (https://rscf. ru/project/25-75-00120/)</funding-statement><funding-statement xml:lang="ru">The study was supported by the Russian Science Foundation, grant No. 25-75-00120 (https://rscf. ru/project/25-75-00120/)</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1.	Ivanets NN, Vinnikova MA, editors. [Narcology: national guidelines]. 3rd ed. Moscow: GEOTAR-Media; 2024. 848 p. Russian.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2.	Shport SV, Klimenko TV, Kirzhanova VV. [State and activities of the narcological service in the Russian Federation in 2022–2023: Analytical review]. Moscow: Serbsky National Medical Research Centre for Psychiatry and Narcology; 2025. 88 p. Russian.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3.	Danpanichkul P, Díaz LA, Suparan K, et al. Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021. Clin Mol Hepatol. 2025;31(2):525–547. doi: 10.3350/cmh.2024.0835</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4.	Prajapati SK, Bhaseen S, Krishnamurthy S, Sahu AN. Neurochemical Evidence of Preclinical and Clinical Reports on Target-Based Therapy in Alcohol Used Disorder. Neurochem Res. 2020;45(2):491–507. doi: 10.1007/s11064-019-02944-9</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5.	Upreti D, Kumar RP, Chen JBJ, et al. Noncoding RNA and Alcohol Use Disorder: A Scoping Review of Current Research and Knowledge Gaps. Alcohol Res. 2025;45(1):06. doi: 10.35946/arcr.v45.1.06</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6.	McPheeters M, O'Connor EA, Riley S, et al. Pharmacotherapy for Alcohol Use Disorder. JAMA. 2023;330(17):1653–1665. doi: 10.1001/jama.2023.19761</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7.	Bahji A, Bach P, Danilewitz M, et al. Comparative efficacy and safety of pharmacotherapies for alcohol withdrawal: a systematic review and network meta-analysis. Addiction. 2022;117(10):2591–2601. doi: 10.1111/add.15853</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8.	Welsh JA, Goberdhan DCI, O'Driscoll L, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404. doi: 10.1002/jev2.12404</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9.	Aquino A, et al. Extracellular vesicles as the drug delivery vehicle for gene-based therapy. Appl Phys Rev. 2025;12(4):041301.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10.	Llach CD, Le GH, Badulescu S, et al. Extracellular vesicles in mood disorders: A systematic review of human studies. Eur Neuropsychopharmacol. 2025;94:59–75. doi: 10.1016/j.euroneuro.2025.02.009</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11.	Gangachannaiah S, Shenoy S, Upadhya D, et al. Potential of extracellular vesicle cargo as molecular signals in Schizophrenia: a scoping review. Schizophrenia (Heidelb). 2025;11(1):17. doi: 10.1038/s41537-025-00566-5</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12.	Tharmalingam J, Gangadaran P, Rajendran RL, Ahn BC. Impact of Alcohol on Inflammation, Immunity, Infections, and Extracellular Vesicles in Pathogenesis. Cureus. 2024;16(3):e56923. doi: 10.7759/cureus.56923</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13.	Togre NS, Bhoj PS, Mekala N, et al. Purinergic and extracellular vesicle signaling in alcohol-induced blood–brain barrier breakdown and neuroimmune activation. Brain Behav Immun. 2025;130:106115. doi: 10.1016/j.bbi.2025.106115</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14.	Severtsev VV, Pavkina MA, Ivanets NN, et al. Extracellular Vesicles as Potential Biomarkers in Addictive Disorders. Biochemistry (Mosc). 2024;89(11):1970–1984. doi: 10.1134/S0006297924110117</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15.	Pascual M, Calvo-Rodriguez M, Núñez L, et al. Toll-like receptors in neuroinflammation, neurodegeneration, and alcohol-induced brain damage. IUBMB Life. 2021;73(7):900–915. doi: 10.1002/iub.2510</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16.	Chung DD, Pinson MR, Bhenderu LS, et al. Toxic and Teratogenic Effects of Prenatal Alcohol Exposure on Fetal Development, Adolescence, and Adulthood. Int J Mol Sci. 2021;22(16):8785. doi: 10.3390/ijms22168785</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17.	Rahman MA, Patters BJ, Kodidela S, Kumar S. Extracellular vesicles: intercellular mediators in alcohol-induced pathologies. J Neuroimmune Pharmacol. 2020;15(3):409–421. doi: 10.1007/s11481-019-09848-z</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18.	Cheng Z, Yang L, Chu H. The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD. J Adv Res. 2025;72:353–367. doi: 10.1016/j.jare.2024.07.002</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19.	Chivero ET, Dagur RS, Peeples ES, et al. Biogenesis, physiological functions and potential applications of extracellular vesicles in substance use disorders. Cell Mol Life Sci. 2021;78(11):4849–4865. doi: 10.1007/s00018-021-03824-8</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20.	Crenshaw BJ, Kumar S, Bell CR, et al. Alcohol Modulates the Biogenesis and Composition of Microglia-Derived Exosomes. Biology (Basel). 2019;8(2):25. doi: 10.3390/biology8020025</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21.	Mukherjee S, Cabrera MA, Boyadjieva NI, et al. Alcohol Increases Exosome Release from Microglia to Promote Complement C1q-Induced Cellular Death of Proopiomelanocortin Neurons in the Hypothalamus in a Rat Model of Fetal Alcohol Spectrum Disorders. J Neurosci. 2020;40(41):7965–7979. doi: 10.1523/JNEUROSCI.0284-20.2020</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22.	Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467–473. doi: 10.7326/M18-0850</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23.	Lötvall J, Hill AF, Hochberg F, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014;3(1):26913. doi: 10.3402/jev.v3.26913</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>24.	Martín-Urdiales B, Perpiñá-Clérigues C, Mellado S, et al. Deciphering Lipidomics Landscape of Urine Extracellular Vesicles in Alcohol Use Disorder Patients. J Proteome Res. 2025;24(11):5653–5663. doi: 10.1021/acs.jproteome.5c00515</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>25.	Perpiñá-Clérigues C, Mellado S, Galiana-Roselló C, et al. Novel insight into the lipid network of plasma extracellular vesicles reveal sex-based differences in the lipidomic profile of alcohol use disorder patients. Biol Sex Differ. 2024;15(1):10. doi: 10.1186/s13293-024-00584-5</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>26.	Perpiñá-Clérigues C, Mellado S, Català-Senent JF, et al. Lipidomic landscape of circulating extracellular vesicles isolated from adolescents exposed to ethanol intoxication: a sex difference study. Biol Sex Differ. 2023;14(1):22. doi: 10.1186/s13293-023-00502-1</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>27.	Ibáñez F, Ureña-Peralta JR, Costa-Alba P, et al. Circulating MicroRNAs in Extracellular Vesicles as Potential Biomarkers of Alcohol-Induced Neuroinflammation in Adolescence: Gender Differences. Int J Mol Sci. 2020;21(18):6730. doi: 10.3390/ijms21186730</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>28.	Yakovlev V, Lapato DM, Rana P, et al. Neuron enriched extracellular vesicles’ MicroRNA expression profiles as a marker of early life alcohol consumption. Transl Psychiatry. 2024;14(1):176. doi: 10.1038/s41398-024-02874-3</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>29.	Kodidela S, Wang Y, Patters BJ, et al. Proteomic profiling of exosomes derived from plasma of HIV- infected alcohol drinkers and cigarette smokers. J Neuroimmune Pharmacol. 2020;15(3):501–519. doi: 10.1007/s11481-019-09853-2</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>30.	Kodidela S, Gerth K, Sinha N, et al. Circulatory Astrocyte and Neuronal EVs as Potential Biomarkers of Neurological Dysfunction in HIV-Infected Subjects and Alcohol/Tobacco Users. Diagnostics (Basel). 2020;10(6):349. doi: 10.3390/diagnostics10060349</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>31.	Kodidela S, Ranjit S, Sinha N, et al. Cytokine profiling of exosomes derived from the plasma of HIV-infected alcohol drinkers and cigarette smokers. PLoS One. 2018;13(7):e0201144. doi: 10.1371/journal.pone.0201144</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>32.	Liu Y, Li J, Bu H, et al. Circular RNA expression alteration identifies a novel circulating biomarker in serum exosomal for detection of alcohol dependence. Addict Biol. 2021;26(6):e13031. doi: 10.1111/adb.13031</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>33.	Wang J, Liang J, Wang JL, et al. Evaluation of plasma-derived extracellular vesicles miRNAs and their connection with hippocampal mRNAs in alcohol use disorder. Life Sci. 2024;351:122820. doi: 10.1016/j.lfs.2024.122820</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>34.	Ande A, McArthur C, Ayuk L, et al. Effect of Mild-to-Moderate Smoking on Viral Load, Cytokines, Oxidative Stress, and Cytochrome P450 Enzymes in HIV-Infected Individuals. PLoS One. 2015;10(4):e0122402. doi: 10.1371/journal.pone.0122402</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>35.	Cecilione JL, Rappaport LM, Hahn SE, et al. Genetic and Environmental Contributions of Negative Valence Systems to Internalizing Pathways. Twin Res Hum Genet. 2018;21(1):12–23. doi: 10.1017/thg.2017.72</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>36.	Suresh PS, Zhang Q. Comprehensive Comparison of Methods for Isolation of Extracellular Vesicles from Human Plasma. J Proteome Res. 2025;24(6):2956–2967. doi: 10.1021/acs.jproteome.5c00149</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>37.	Amonker S, Houshmand A, Hinkson A, et al. Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis. Hepatol Commun. 2023;7(5):e0133. doi: 10.1097/HC9.0000000000000133</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>38.	Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319(5867):1244–1247. doi: 10.1126/science.1153124</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>39.	Skotland T, Hessvik NP, Sandvig K, Llorente A. Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology. J Lipid Res. 2019;60(1):9–18. doi: 10.1194/jlr.R084343</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>40.	Ibáñez F, Montesinos J, Area-Gomez E, et al. Ethanol Induces Extracellular Vesicle Secretion by Altering Lipid Metabolism through the Mitochondria-Associated ER Membranes and Sphingomyelinases. Int J Mol Sci. 2021;22(16):8438. doi: 10.3390/ijms22168438</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>41.	Jeon S, Carr R. Alcohol effects on hepatic lipid metabolism. J Lipid Res. 2020;61(4):470–479. doi: 10.1194/jlr.R119000547</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>42.	Krämer-Albers EM. Extracellular Vesicles at CNS barriers: Mode of action. Curr Opin Neurobiol. 2022;75:102569. doi: 10.1016/j.conb.2022.102569</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>43.	Forró T, Manu DR, Băjenaru OL, Bălașa R. GFAP as Astrocyte-Derived Extracellular Vesicle Cargo in Acute Ischemic Stroke Patients — A Pilot Study. Int J Mol Sci. 2024;25(11):5726. doi: 10.3390/ijms25115726</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>44.	Edwardson MA, Mitsuhashi M, van Epps D. Elevation of astrocyte-derived extracellular vesicles over the first month post-stroke in humans. Sci Rep. 2024;14(1):5272. doi: 10.1038/s41598-024-55983-w</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>45.	Chrostek L, Panasiuk A. Liver fibrosis markers in alcoholic liver disease. World J Gastroenterol. 2014;20(25):8018–8023. doi: 10.3748/wjg.v20.i25.8018</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>46.	Vandooren J, Itoh Y. Alpha-2-Macroglobulin in Inflammation, Immunity and Infections. Front Immunol. 2021;12:803244. doi: 10.3389/fimmu.2021.803244</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>47.	Mitaki S, Wada Y, Sheikh AM, et al. Proteomic analysis of extracellular vesicles enriched serum associated with future ischemic stroke. Sci Rep. 2021;11(1):24024. doi: 10.1038/s41598-021-03497-0</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>48.	Lesher AM, Nilsson B, Song WC. Properdin in complement activation and tissue injury. Mol Immunol. 2013;56(3):191–198. doi: 10.1016/j.molimm.2013.06.002</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>49.	Ganesh S, Lam TT, Garcia-Milian R, et al. Peripheral signature of altered synaptic integrity in young onset cannabis use disorder: A proteomic study of circulating extracellular vesicles. World J Biol Psychiatry. 2023;24(7):603–613. doi: 10.1080/15622975.2023.2197039</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>50.	Tóth EÁ, Turiák L, Visnovitz T, et al. Formation of a protein corona on the surface of extracellular vesicles in blood plasma. J Extracell Vesicles. 2021;10(11):e12140. doi: 10.1002/jev2.12140</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>51.	Adams C, Conigrave JH, Lewohl J, et al. Alcohol use disorder and circulating cytokines: A systematic review and meta-analysis. Brain Behav Immun. 2020;89:501–512. doi: 10.1016/j.bbi.2020.08.002</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>52.	Pan YC, Chiu YC, Lin YH. Systematic review and meta-analysis of epidemiology of internet addiction. Neurosci Biobehav Rev. 2020;118:612–622. doi: 10.1016/j.neubiorev.2020.08.013</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>53.	Starkman BG, Sakharkar AJ, Pandey SC. Epigenetics — Beyond the Genome in Alcoholism. Alcohol Res. 2012;34(3):293–305. doi: 10.35946/arcr.v34.3.04</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>54.	Kong EQZ, Subramaniyan V, Lubau NSA. Uncovering the impact of alcohol on internal organs and reproductive health: Exploring TLR4/NF‐kB and CYP2E1/ROS/Nrf2 pathways. Animal Model Exp Med. 2024;7(4):444–459. doi: 10.1002/ame2.12436</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>55.	Crews FT, Sarkar DK, Qin L, et al. Neuroimmune Function and the Consequences of Alcohol Exposure. Alcohol Res. 2015;37(2):331–341, 344–351. doi: 10.35946/arcr.v37.2.15</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>56.	de Timary P, Stärkel P, Delzenne NM, Leclercq S. A role for the peripheral immune system in the development of alcohol use disorders? Neuropharmacology. 2017;122:148–160. doi: 10.1016/j.neuropharm.2017.04.013</mixed-citation></ref></ref-list></back></article>
